Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils - PubMed (original) (raw)

. 2009 Oct-Dec;22(4):897-909.

doi: 10.1177/039463200902200405.

P Rosenstiel, M Romero-Ramos, A Arlt, H Schäfer, D Seegert, P J Kahle, S Odoy, J H Claasen, C Holzknecht, L O Brandenburg, G Deuschl, S Schreiber, D Kirik, R Lucius

Affiliations

• PMID: 20074453
• DOI: 10.1177/039463200902200405

Free article

Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils

H Wilms et al. Int J Immunopathol Pharmacol. 2009 Oct-Dec.

Free article

Abstract

Alpha-Synuclein (alpha-Syn) accounts, as a major component of Lewy bodies (LB), for the filamentous deposits in many cases of neurodegenerative diseases. Yet, little is known about the molecular mechanisms of neuronal loss in these diseases. The correlation between alpha-Syn oligomerization/aggregation and pathologies raises the key question of which molecular form of alpha-Syn (i.e. monomeric alpha-Syn, protofibrils or mature fibrils) represents the damage-inducing culprit in the scenario of synucleinopathies. We show that human alpha-Syn protofibrils (PFs) are potent activators of parallel proinflammatory signalling pathways (p38 and ERK1/2 MAP kinases and NF-kappaB) in microglial cells in vitro. Furthermore, stereotactic injection of alpha-Syn PFs into the substantia nigra of adult rats leads to a profound activation of microglia and adjacent neuronal cell loss, which can be attenuated by the MAP kinase inhibitor semapimod. We propose that the neurodegenerative process of alpha-synucleinopathies involves microglial activation through alpha-Syn released or extruded from cells with pathogenic alpha-Syn metabolism. Compounds that inhibit the MAPK/NF-kappaB pathways might be a promising pharmacological strategy for the treatment of the inflammatory component of synucleinopathies including PD.

PubMed Disclaimer

Similar articles

• ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
  Xu Z, Wang BR, Wang X, Kuang F, Duan XL, Jiao XY, Ju G. Xu Z, et al. Life Sci. 2006 Oct 12;79(20):1895-905. doi: 10.1016/j.lfs.2006.06.023. Epub 2006 Jun 21. Life Sci. 2006. PMID: 16978658
• α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway.
  Prabhakaran K, Chapman GD, Gunasekar PG. Prabhakaran K, et al. Toxicol Mech Methods. 2011 Jul;21(6):435-43. doi: 10.3109/15376516.2011.560210. Epub 2011 Mar 21. Toxicol Mech Methods. 2011. PMID: 21417633
• Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
  Lee CW, Lin WN, Lin CC, Luo SF, Wang JS, Pouyssegur J, Yang CM. Lee CW, et al. J Cell Physiol. 2006 Apr;207(1):174-86. doi: 10.1002/jcp.20549. J Cell Physiol. 2006. PMID: 16288471
• Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation.
  Chavarría C, Ivagnes R, Souza JM. Chavarría C, et al. Biomolecules. 2022 Apr 30;12(5):655. doi: 10.3390/biom12050655. Biomolecules. 2022. PMID: 35625583 Free PMC article. Review.
• The Interplay between α-Synuclein and Microglia in α-Synucleinopathies.
  Deyell JS, Sriparna M, Ying M, Mao X. Deyell JS, et al. Int J Mol Sci. 2023 Jan 27;24(3):2477. doi: 10.3390/ijms24032477. Int J Mol Sci. 2023. PMID: 36768798 Free PMC article. Review.

Cited by

• Predictive value of α-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.
  Razia R, Majeed F, Amin R, Mukhtar S, Mahmood K, Abualait T, Bashir S, Baig DN. Razia R, et al. PLoS One. 2023 Aug 3;18(8):e0285022. doi: 10.1371/journal.pone.0285022. eCollection 2023. PLoS One. 2023. PMID: 37535585 Free PMC article.
• The role of innate and adaptive immunity in Parkinson's disease.
  Kannarkat GT, Boss JM, Tansey MG. Kannarkat GT, et al. J Parkinsons Dis. 2013;3(4):493-514. doi: 10.3233/JPD-130250. J Parkinsons Dis. 2013. PMID: 24275605 Free PMC article. Review.
• GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF- κ B Pathways in LPS-Stimulated Microglial Cells.
  He GY, Yuan CG, Hao L, Xu Y, Zhang ZX. He GY, et al. Evid Based Complement Alternat Med. 2014;2014:368598. doi: 10.1155/2014/368598. Epub 2014 Mar 24. Evid Based Complement Alternat Med. 2014. PMID: 24782908 Free PMC article.
• The multi-target effects of CNI-1493: convergence of anti-amylodogenic and anti-inflammatory properties in animal models of Alzheimer's disease.
  Sankowski R, Herring A, Keyvani K, Frenzel K, Wu J, Röskam S, Noelker C, Bacher M, Al-Abed Y. Sankowski R, et al. Mol Med. 2016 Dec;22:776-788. doi: 10.2119/molmed.2016.00163. Epub 2016 Nov 15. Mol Med. 2016. PMID: 27847962 Free PMC article.
• Alpha-synuclein oligomers: a new hope.
  Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J. Bengoa-Vergniory N, et al. Acta Neuropathol. 2017 Dec;134(6):819-838. doi: 10.1007/s00401-017-1755-1. Epub 2017 Aug 12. Acta Neuropathol. 2017. PMID: 28803412 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Miscellaneous

  • NCI CPTAC Assay Portal